Never miss a story

Get subscribed to our newsletter


×
Photo by Unsplash

The outcomes of the results of this research were recently published in a journal (BioRxIV) and a joint patent has been filed both in India as well.

Amid the rush to develop cures for the coronavirus, a study by a University of Hyderabad (UoH) incubated startup, has discovered that an anti-diabetic drug has potential use as a ready to use, cost-effective solution for safely treating Covid patients.

In-vitro and in-silico studies conducted by ReaGene Innovations Private Limited, a startup company incubated at the ASPIRE-BioNEST, and INDRAS Private Limited, indicate that re-purposing the anti-diabetic drug Ertugliflozin might provide a therapeutic solution to the Covid-19 infection.

Ertugliflozin, an FDA approved drug for type-2 diabetes, works as an SGLT-2 inhibitor by removing excess glucose through urine.

The research findings indicate that this re-purposed drug not only binds effectively to the receptor-binding domain of the spike protein of Covid-19 and further blocks binding to human ACE2 but also displays significant anti-inflammatory and anti-thrombotic properties in a 3D human vascular lung model, both of which are fundamentals in Covid infection.

This is the first result that offers a safe, ready-to-use, cost-effective solution to humans who contract Covid.

"It has immense potential to treat Covid infection, and our research proves its efficacy in the test-tube assays", said Dr Uday Saxena, CEO of ReaGene Innovations, co-founded with Dr Subramanyam Vangala, and Dr Sreedhara Voleti, MD of INDRAS.

Covid This is the first result that offers a safe, ready-to-use, cost-effective solution to humans who contract Covid. Photo by Unsplash


INDRAS focus is on consulting, contracting, and collaborative solutions to in-silico drug design have prioritized about 8,000 FDA approved drugs to top-10 from their computational studies, which were further experimented by ReaGene Innovations for various in-vitro assays on cytokine storm, antithrombotic properties, and inflammatory marker reduction through various in vitro assays.

The path to finding such a re-purposed drug was critically planned and completed within a year of funding from the IT giant, Tech Mahindra.

The outcomes of the results of this research were recently published in a journal (BioRxIV) and a joint patent has been filed both in India as well as internationally under Patent Cooperation Treaty.

ALSO READ What makes says cov 2 more deadly

The results obtained are highly encouraging, and further in animal models towards preclinical, and clinical outcomes in humans are yet to be conducted for this drug to be officially nominated as a therapeutic agent for COVID-19, the company said in a statement.

ASPIRE-BioNEST is a life sciences incubator jointly funded by BIRAC, a section-8 not-for-profit organization of the Department of Biotechnology, Govt of India, and the University of Hyderabad (UoH) for nurturing scaling technologies through entrepreneurship. (IANS/AD)


Popular

Wikimedia

Katrina Kaif and Vicky Kaushal are scheduled to reach Hotel Six Senses Fort Barwara located at Chauth Ka Barwara, by 9 p.m. on Monday.

Final preparations are in full swing at Six Senses Fort Barwara which will host the much talked about wedding of celebrity couple Vicky Kaushal and Katrina Kaif.

According to sources, the event company working for this wedding has procured crystal balls and chandeliers from abroad to give a royal look to the wedding. These will be installed in the hotel soon.

Keep Reading Show less
Unsplash

Meta-owned WhatsApp on Monday announced an incubator programme in India.

Meta-owned WhatsApp on Monday announced an incubator programme in India that will select 10 organisations and help them build digital solutions to tackle critical health issues.

Called the WhatsApp Incubator Programme (WIP), the initiative aims to facilitate positive and measurable health outcomes at scale by leveraging the WhatsApp Business Platform.

Keep Reading Show less
Unsplash

India has to define its stand and negotiate its international policy keeping in view the nation's best interests of the long run.

By D.C. Pathak

Advent of Biden Presidency with its resonating calls of 'America is back', 'we will repair our alliances' and 'will engage with the world once again' on one hand and the rise of President Xi Jinping with a stronger hold on China after the Plenary session of the 19th Central Committee of CPC, on the other, have got strategic analysts to examine if a new Cold War was already on the horizon.

Keep reading... Show less